Capital Fund Management (CFM)
STOK icon

Capital Fund Management (CFM)’s Stoke Therapeutics STOK Stock Holding History

Capital Fund Management (CFM)’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,717
Closed -$372K – 2523
2025
Q4 		$372K Buy
+11,717
New +$352K ﹤0.01% 2266

Other funds holding STOK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Capital Fund Management (CFM)'s STOK Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 11,717 shares — an estimated $372K sold.

Capital Fund Management (CFM) first reported a position in STOK in Q4 2025 and held it in 1 quarter. The position peaked at $372K in Q4 2025. 198 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 11,717 Stoke Therapeutics shares in Q1 2026, an estimated $372K.
  • Capital Fund Management (CFM) first reported a position in Stoke Therapeutics in Q4 2025 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Stoke Therapeutics position peaked at $372K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.